Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a biotech company pioneering the telomere platform in the industry with applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. The Company's lead application, TELO-MM is being developed to provide actionable information to medical professionals in the treatment of multiple myeloma, a form of blood cancer. Its clinical studies and product development design includes TeloView SMM, TeloView Test to Predict Patient Resistance to Treatment, development in collaboration with the Mayo Clinic and TeloView Test to monitor minimal residual disease in MM patients. The Company, by combining quantitative analysis of three-dimensional telomeres with molecular biology and artificial intelligence to recognize disease associated genetic instability, is developing products that improve day-to-day care for patients by serving the needs of pathologists, clinicians, academic researchers and drug developers.

TSXV:TELO - Post by User

Telo Genomics Corp

Bullboard Posts

Comment by gooddogon Jan 13, 2017 1:49pm

111 Views

Post# 25705324

RE:RE:JP Morgan biotech conference. 3D had a busy 3 days I hear.

colima wrote: I have searched & searched for something about DXD at the conference. And I have found NOTHING. Could you pinpoint something? Thank you.

The posts are a "he said,she said", there is no media or company publication that confirms the company's attendance. There is only specualation that they did so until such time as there is an official announcement.

Bullboard Posts

Canadian artificial intelligence ETFs